In 2008 the University of Kansas sued the National Institutes of Health over the inventorship credit on patents for the blood cancer drug Velcade. The dispute came to an end on Friday when Pillsbury Winthrop Shaw Pittman, which represented Kansas, announced that an arbitration panel had determined that a professor and a research assistant at the university were indeed co-inventors of the patents.
Pillsbury Helps University of Kansas Win Co-Inventor Credit for Blood Cancer Drug
The Litigation Daily
April 6, 2012
This content is now available at LexisNexis®.
The ALM® and LexisNexis® Content Alliance
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM’s legal news publications. LexisNexis® customers will be able to access and use ALM’s content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM’s other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM’s content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
If you are not currently a LexisNexis subscriber, contact 1-800-227-4908 to find out more or click here to have a customer representative contact you directly.